Clinical trial
Post-Approval Study of the HeartLight Endoscopic Ablation System for the Treatment of Atrial Fibrillation
NCT03168659 is registered in ClinicalTrials.gov with CardioFocus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Approval Study of the HeartLight Endoscopic Ablation System for the Treatment of Atrial Fibrillation
- Lead sponsor
- CardioFocus
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 16, 2017
- Completion date
- October 31, 2028
- Enrollment
- 250 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.